Literature DB >> 11422737

Apoptosis and JNK activation are differentially regulated by Fas expression level in renal tubular epithelial cells.

S Khan1, A Koepke, G Jarad, K Schlessman, R P Cleveland, B Wang, M Konieczkowski, J R Schelling.   

Abstract

BACKGROUND: In chronic renal disease, renal tubular epithelial cell (RTC) Fas expression is up-regulated, leading to apoptotic RTC deletion and tubular atrophy. In vitro, cytokine- or hypoxia-induced up-regulation of Fas expression is associated with RTC apoptosis. In contrast, constitutively expressed, low level RTC Fas does not mediate apoptosis, suggesting that Fas may be coupled to expression level-dependent RTC signaling pathways. Fas is known to signal through JNK in many systems, but the requirement of JNK activation for apoptosis remains controversial.
METHODS: To determine if RTC Fas regulates JNK activity and apoptosis, human RTC were transfected with graded concentrations of a eukaryotic expression vector for murine Fas. Apoptosis was measured by annexin V, TUNEL and PARP cleavage assays. JNK activity was determined by immune complex kinase assay and/or immunoblots with phospho-specific JNK antibodies, in the presence or absence of co-expressed dominant negative JNK constructs.
RESULTS: Fas antibody stimulation of RTC with high Fas expression levels (to model RTC phenotype in renal disease) caused a tenfold increase in apoptosis, while RTC with low level Fas expression (to model normal RTC phenotype) were apoptosis-resistant. Fas ligation activated JNK in RTC expressing low levels of Fas, but not in apoptosis-sensitive RTC with increased Fas expression. Dominant negative JNK co-expression failed to inhibit apoptosis in RTC expressing high levels of Fas, suggesting that JNK is neither necessary, nor sufficient, for Fas-dependent apoptosis.
CONCLUSIONS: At high levels of expression, RTC Fas promotes apoptosis in a JNK-independent manner. At low basal expression, Fas induces JNK activation, but not apoptosis, consistent with novel roles for RTC Fas as a mediator of cell stress or chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422737     DOI: 10.1046/j.1523-1755.2001.00771.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Mesangial cell integrin αvβ8 provides glomerular endothelial cell cytoprotection by sequestering TGF-β and regulating PECAM-1.

Authors:  Shenaz Khan; Sujata Lakhe-Reddy; Joseph H McCarty; Christine M Sorenson; Nader Sheibani; Louis F Reichardt; Jane H Kim; Bingcheng Wang; John R Sedor; Jeffrey R Schelling
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Beta8 integrin binds Rho GDP dissociation inhibitor-1 and activates Rac1 to inhibit mesangial cell myofibroblast differentiation.

Authors:  Sujata Lakhe-Reddy; Shenaz Khan; Martha Konieczkowski; George Jarad; Karen L Wu; Louis F Reichardt; Yoshimi Takai; Leslie A Bruggeman; Bingcheng Wang; John R Sedor; Jeffrey R Schelling
Journal:  J Biol Chem       Date:  2006-05-11       Impact factor: 5.157

3.  Chronic hepatitis B serum promotes apoptotic damage in human renal tubular cells.

Authors:  Cun-Liang Deng; Xin-Wen Song; Hai-Jun Liang; Chen Feng; Yun-Jian Sheng; Ming-Yong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 4.  TNF superfamily: a growing saga of kidney injury modulators.

Authors:  Maria D Sanchez-Niño; Alberto Benito-Martin; Sara Gonçalves; Ana B Sanz; Alvaro C Ucero; Maria C Izquierdo; Adrian M Ramos; Sergio Berzal; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  Mediators Inflamm       Date:  2010-10-04       Impact factor: 4.711

5.  TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects.

Authors:  Vinh Nguyen; Cornelia Cudrici; Valentina Zernetkina; Florin Niculescu; Horea Rus; Cynthia Drachenberg; Violeta Rus
Journal:  Clin Immunol       Date:  2009-04-05       Impact factor: 3.969

Review 6.  Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications.

Authors:  José M López-Novoa; Ana B Rodríguez-Peña; Alberto Ortiz; Carlos Martínez-Salgado; Francisco J López Hernández
Journal:  J Transl Med       Date:  2011-01-20       Impact factor: 5.531

Review 7.  Apoptosis: Activation and Inhibition in Health and Disease.

Authors:  Sandra Georgina Solano-Gálvez; Jack Abadi-Chiriti; Luis Gutiérrez-Velez; Eduardo Rodríguez-Puente; Enrique Konstat-Korzenny; Diego-Abelardo Álvarez-Hernández; Giorgio Franyuti-Kelly; Laila Gutiérrez-Kobeh; Rosalino Vázquez-López
Journal:  Med Sci (Basel)       Date:  2018-07-04

8.  Interferon-γ Reduces the Proliferation of Primed Human Renal Tubular Cells.

Authors:  Omar García-Sánchez; José Miguel López-Novoa; Francisco J López-Hernández
Journal:  Nephron Extra       Date:  2014-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.